Literature DB >> 22820720

Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease.

Vladana Spica1, Tatjana Pekmezović, Marina Svetel, Vladimir S Kostić.   

Abstract

Non-motor symptoms (NMS) of Parkinson's disease (PD) have only recently been increasingly recognized for their impact on a patient's quality of life. In this study, we applied the validated, comprehensive self-completed NMS questionnaire for PD (NMS Quest) to 101 patients with young-onset PD (onset between 21 and 45 years, YOPD) and 107 patients with late-onset PD (onset of PD ≥ 55 years, LOPD). The mean total NMS (NMSQ-T) was 11.9 ± 6.0 (range: 0 to of a maximum of 26) in LOPD and 7.7 ± 5.8 (range: 0 to of a maximum of 26) in YOPD (p < 0.05). Compared to YOPD, dribbling of saliva, loss of taste/smell, nocturia, forgetfulness, loss of interest, hallucinations, lack of concentration, anxiety, change in libido and difficulty in sexual activities, were significantly more prevalent in LOPD. The only NMS more prevalent in YOPD were restless legs and sweating, although such findings might be associated with drug effects. Among the nine NMS Quest domains, in both LOPD and YOPD patients the three most prevalent domains were depression/anxiety, urinary and sexual. Also, in both groups, hallucinations/delusions had the lowest frequency. In the multivariate linear regression model, the Hoehn and Yahr (HY) stage of the disease and activities of daily living scores in YOPD patients, while only the HY stage in LOPD patients appeared to be statistically significant predictors of increasing number of NMS. In contrast to a previous suggestion that YOPD patients might have an increased risk for NMS, we found a higher prevalence of NMS in LOPD patients than in those with YOPD.

Entities:  

Mesh:

Year:  2012        PMID: 22820720     DOI: 10.1007/s00415-012-6600-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Nonmotor symptoms in Parkin gene-related parkinsonism.

Authors:  Georg Kägi; Christine Klein; Nicholas W Wood; Susanne A Schneider; Peter P Pramstaller; Vera Tadic; Niall P Quinn; Bart P C van de Warrenburg; Kailash P Bhatia
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

Review 2.  Nonmotor disturbances in Parkinson's disease.

Authors:  Claudio L Bassetti
Journal:  Neurodegener Dis       Date:  2010-12-23       Impact factor: 2.977

3.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Restless legs syndrome in Parkinson's disease.

Authors:  Juan C Gómez-Esteban; Juan J Zarranz; Beatriz Tijero; Fernando Velasco; Joseba Barcena; Idoia Rouco; Elena Lezcano; María C Lachen; Amaia Jauregui; Amaia Ugarte
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

7.  Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.

Authors:  A Schrag; Y Ben-Shlomo; R Brown; C D Marsden; N Quinn
Journal:  Mov Disord       Date:  1998-11       Impact factor: 10.338

8.  Factors contributing to the development of restless legs syndrome in patients with Parkinson disease.

Authors:  Ji E Lee; Hae-Won Shin; Kyung S Kim; Young H Sohn
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

9.  Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease.

Authors:  V Kostic; S Przedborski; E Flaster; N Sternic
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

10.  The Frequency of Nonmotor Symptoms among Advanced Parkinson Patients May Depend on Instrument Used for Assessment.

Authors:  Nelson Hwynn; Ihtsham U Haq; Irene A Malaty; Andrew S Resnick; Michael S Okun; Danica S Carew; Genko Oyama; Yunfeng Dai; Samuel S Wu; Ramon L Rodriguez; Charles E Jacobson; Hubert H Fernandez
Journal:  Parkinsons Dis       Date:  2011-07-26
View more
  19 in total

Review 1.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

2.  Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.

Authors:  Renata Pietsch Ribeiro; Eduardo Luiz Gasnhar Moreira; Danúbia Bonfanti Santos; Dirleise Colle; Alessandra Antunes Dos Santos; Kaite Cristiane Peres; Claudia Pinto Figueiredo; Marcelo Farina
Journal:  Neurochem Res       Date:  2013-01-19       Impact factor: 3.996

3.  The association between symptoms of sexual dysfunction and age at onset in Parkinson's disease.

Authors:  Tuba Özcan; Erdal Benli; Feriha Özer; Esra Yancar Demir; Yasemin Kaya; Ali Ayyıldız
Journal:  Clin Auton Res       Date:  2016-05-17       Impact factor: 4.435

4.  Validation and cross-cultural adaptation of the Self-Assessment Disability Scale in patients with Parkinson's disease in Serbia.

Authors:  Tatjana Gazibara; Iva Stankovic; Aleksandra Tomic; Marina Svetel; Darija Kisic Tepavcevic; Vladimir S Kostic; Tatjana Pekmezovic
Journal:  J Neurol       Date:  2013-04-07       Impact factor: 4.849

Review 5.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 6.  A Practical Approach to Early-Onset Parkinsonism.

Authors:  Giulietta M Riboldi; Emanuele Frattini; Edoardo Monfrini; Steven J Frucht; Alessio Di Fonzo
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

7.  The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients.

Authors:  Roberto Erro; Carmine Vitale; Marianna Amboni; Marina Picillo; Marcello Moccia; Katia Longo; Gabriella Santangelo; Anna De Rosa; Roberto Allocca; Flavio Giordano; Giuseppe Orefice; Giuseppe De Michele; Lucio Santoro; Maria Teresa Pellecchia; Paolo Barone
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

8.  Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's disease.

Authors:  Ondrej Fiala; Daniela Zahorakova; Lenka Pospisilova; Jana Kucerova; Milada Matejckova; Pavel Martasek; Jan Roth; Evzen Ruzicka
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

Review 9.  The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.

Authors:  Matej Skorvanek; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2016-09-08

10.  Nonmotor Features in Parkinson's Disease: What Are the Most Important Associated Factors?

Authors:  Liis Kadastik-Eerme; Mari Muldmaa; Stella Lilles; Marika Rosenthal; Nele Taba; Pille Taba
Journal:  Parkinsons Dis       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.